1. Home
  2.  » 
  3. Expert Content
  4.  » 
  5. Inhalation
  6.  » Orally Inhaled & Nasal Drug Delivery – An Evolving Pipeline Creating New Opportunities

Orally Inhaled & Nasal Drug Delivery – An Evolving Pipeline Creating New Opportunities

Summary: Catalent’s Carla Vozone discusses the significant trends in the Orally Inhaled & Nasal Drug Delivery (OINDP) segment including larger molecules and novel indications. She also discusses changes within CDMOs and various challenges facing the industry. Download the e-book to learn more.

View the eBook